Amanda Kirane, M.D.

Amanda Robinson Kirane, M.D.

Specialties

Skin Cancer and Melanoma

Surgery - Oncology

Minimally Invasive Surgery

Robotic Surgery

Title

  • Assistant Professor
To see if Amanda Robinson Kirane is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).

UC Davis Comprehensive Cancer Center

2279 45th Street
Sacramento, CA 95817
Driving Directions

Primary Phone:
800-362-5566
916-734-5959

Additional Phone Numbers

Physician Referrals: 800-4-UCDAVIS (800-482-3284)

Emails

Personal:
arkirane@ucdavis.edu

Social Networking

Twitter:
https://twitter.com/amandakirane

Philosophy of Care

Dr. Kirane aims to provide compassionate care as a partnership with her patients and their families with respect to each patient's individual needs.  In complex cases, a multi-disciplinary team of specialists within the cancer center will collaboratively coordinate in effort to help guide our patients in decision making to ensure the highest quality care.

Clinical Interests

Dr. Kirane is a fellowship trained Complex General Surgical Oncologist with  specialty training in Melanoma, other skin cancers, and soft tissue diseases as well as minimally invasive approaches to oncologic surgery in soft tissue, gastric, and hepatobiliary cancers.

Her clinical interests include regional therapies for locally advanced soft tissue cancers, including isolated limb infusion, as well as evolving technologies and therapies in advanced melanoma cases. She passionately believes in personalized medicine using evidence-based best practice to tailor treatment to each individual patient. 

Research/Academic Interests

Dr. Kirane's academic interests include basic and translational science research in melanoma and sarcoma with specific interest in mechanisms of evasive resistance, tumor microenvironment signaling and immune response. Being able to move from bench to bedside and return allows for the rapid adaptation of surgical science to improved patient care.  

Her previous bench work has resulted in multiple ongoing trials of novel therapeutic strategies in pancreatic cancer. She is also invested in surgical education and clinical trials for novel targets in resistant melanoma. 

Division

Surgical Oncology

Center/Program Affiliation

UC Davis Comprehensive Cancer Center

Education

M.D., University of Texas Southwestern Medical School, Dallas TX 2006

B.A., University of Texas, Austin TX 2002

Residency

General Surgery, Southwestern Medical Center, Dallas TX 2007-2009, 2012-2014

Fellowships

Physician-Scientist in Oncology, Hamon Center for Therapeutic Oncology Research, Dallas TX 2009-2012

Complex General Surgical Oncology, Memorial Sloan Kettering Cancer Center, New York NY 2014-2016

Board Certifications

da Vinci Surgery in General Surgical Oncology,

Professional Memberships

American Association of Cancer Research

American College of Surgery

Association of Academic Surgeons

Association of Women Surgeons

Connective Tissue Oncology Society

Society of Surgical Oncology

The Society for Melanoma Research

Honors and Awards

David and Monica Gorin Award of Courage Fellow, Memorial Sloan Kettering Cancer Center, 2015

Society of Surgical Oncology, Best Basic/Translational Science Award, 2015

Select Recent Publications

Kirane A, Crago AM. The importance of surgical margins in retroperitoneal sarcoma. J Surg Oncol. 2016 Mar;113(3):270-6.

 Kiranea, A and Brennan, MF. The Management of Soft TIssue Sarcoma, Cameron Current Surgical Therapy 12th edition. 2016.

Kirane A, Ludwig KF, Sorrelle N, Haaland G, Sandal T, Ranaweera R, Toombs JE,  Wang M, Dineen SP, Micklem D, Dellinger MT, Lorens JB, Brekken RA. Warfarin Blocks Gas6-Mediated Axl Activation Required for Pancreatic Cancer Epithelial Plasticity and Metastasis. Cancer Res. 2015 Sep 15;75(18):3699-705.

Kirane A, Toombs JE, Ostapoff K, Carbon JG, Zaknoen S, Braunfeld J, Schwarz RE, Burrows FJ, Brekken RA. Apricoxib, a novel inhibitor of COX-2, markedly improves standard therapy response in molecularly defined models of pancreatic cancer. Clin Cancer Res. 2012 Sep 15;18(18):5031-42.

Kirane A, Toombs JE, Larsen JE, Ostapoff KT, Meshaw KR, Zaknoen S, Brekken RA, Burrows FJ. Epithelial-mesenchymal transition increases tumor sensitivity to COX-2 inhibition by apricoxib. Carcinogenesis. 2012 Sep;33(9):1639-46.

Awasthi N, Kirane A, Schwarz MA, Toombs JE, Brekken RA, Schwarz RE. Smac mimetic-derived augmentation of chemotherapeutic response in experimental pancreatic cancer. BMC Cancer. 2011 Jan 12;11:15.

Bao JJ, Mansour JC, Timmerman RD, Kirane A, Ewing GE, Schwarz RE. Intraduodenal sarcoma recurrence of retroperitoneal origin: an unusual cause for  a duodenal obstruction. World J Surg Oncol. 2012 Apr 20;10:59.